Susquehanna International Group
ONC

Susquehanna International Group’s BeOne Medicines Ltd ONC Stock Holding History

Susquehanna International Group’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.6M Buy
42,400
+4,200
+11% +$1.36M ﹤0.01% 2779
2025
Q4 		$11.6M Buy
38,200
+6,400
+20% +$2.09M ﹤0.01% 2867
2025
Q3 		$10.8M Buy
31,800
+5,900
+23% +$1.79M ﹤0.01% 2939
2025
Q2 		$6.27M Sell
25,900
-2,400
-8% -$589K ﹤0.01% 3576
2025
Q1 		$7.7M Sell
28,300
-19,700
-41% -$4.61M ﹤0.01% 2891
2024
Q4 		$8.87M Sell
48,000
-56,700
-54% -$11.6M ﹤0.01% 2810
2024
Q3 		$23.5M Buy
104,700
+58,000
+124% +$10.4M ﹤0.01% 1662
2024
Q2 		$6.66M Sell
46,700
-18,000
-28% -$2.77M ﹤0.01% 3003
2024
Q1 		$10.1M Buy
64,700
+32,000
+98% +$5.15M ﹤0.01% 2589
2023
Q4 		$5.9M Sell
32,700
-600
-2% -$109K ﹤0.01% 3440
2023
Q3 		$5.99M Buy
33,300
+14,000
+73% +$2.77M ﹤0.01% 3240
2023
Q2 		$3.44M Sell
19,300
-25,800
-57% -$5.94M ﹤0.01% 4141
2023
Q1 		$9.72M Buy
45,100
+29,100
+182% +$6.98M ﹤0.01% 2495
2022
Q4 		$3.52M Buy
16,000
+10,300
+181% +$1.89M ﹤0.01% 3764
2022
Q3 		$768K Sell
5,700
-3,200
-36% -$550K ﹤0.01% 7338
2022
Q2 		$1.44M Sell
8,900
-1,000
-10% -$156K ﹤0.01% 5645
2022
Q1 		$1.87M Sell
9,900
-23,900
-71% -$5.08M ﹤0.01% 5634
2021
Q4 		$9.16M Buy
33,800
+14,600
+76% +$4.93M ﹤0.01% 2852
2021
Q3 		$6.97M Buy
19,200
+17,500
+1,029% +$5.72M ﹤0.01% 3412
2021
Q2 		$583K Sell
1,700
-3,500
-67% -$1.16M ﹤0.01% 9230
2021
Q1 		$1.81M Sell
5,200
-1,600
-24% -$530K ﹤0.01% 6163
2020
Q4 		$1.76M Sell
6,800
-19,100
-74% -$5.26M ﹤0.01% 5373
2020
Q3 		$7.42M Buy
25,900
+8,500
+49% +$2M ﹤0.01% 2568
2020
Q2 		$3.28M Sell
17,400
-20,000
-53% -$3.26M ﹤0.01% 3647
2020
Q1 		$4.6M Buy
37,400
+18,000
+93% +$2.81M ﹤0.01% 2688
2019
Q4 		$3.22M Sell
19,400
-13,800
-42% -$2.29M ﹤0.01% 3586
2019
Q3 		$4.07M Buy
33,200
+17,300
+109% +$2.3M ﹤0.01% 3011
2019
Q2 		$1.97M Sell
15,900
-28,800
-64% -$3.66M ﹤0.01% 4195
2019
Q1 		$5.9M Buy
44,700
+22,400
+100% +$3.02M ﹤0.01% 2268
2018
Q4 		$3.13M Sell
22,300
-22,000
-50% -$2.92M ﹤0.01% 2877
2018
Q3 		$7.63M Sell
44,300
-4,200
-9% -$706K ﹤0.01% 2193
2018
Q2 		$7.46M Sell
48,500
-85,900
-64% -$15.3M ﹤0.01% 2257
2018
Q1 		$22.6M Buy
134,400
+99,200
+282% +$13.4M 0.01% 1131
2017
Q4 		$3.44M Sell
35,200
-1,600
-4% -$146K ﹤0.01% 3040
2017
Q3 		$3.81M Buy
+36,800
New +$2.74M ﹤0.01% 2882

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Susquehanna International Group's ONC Position: Q1 2026 in Review

Susquehanna International Group increased its BeOne Medicines Ltd (ONC) stake by 321% in Q1 2026, buying an estimated $3.65M and bringing the position to 14,808 shares worth $4.4M. The position accounts for ﹤0.01% of the portfolio, ranked #4471.

Susquehanna International Group first reported a position in ONC in Q3 2016 and has held it in 24 quarters since. The position peaked at $6.07M in Q1 2020. 282 funds tracked by Wall St. Rank hold ONC as of Q1 2026.

  • Susquehanna International Group held 14,808 shares of BeOne Medicines Ltd worth $4.4M as of Q1 2026.
  • Susquehanna International Group bought 11,291 BeOne Medicines Ltd shares in Q1 2026, an estimated $3.65M.
  • BeOne Medicines Ltd made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #4471 holding.
  • Susquehanna International Group first reported a position in BeOne Medicines Ltd in Q3 2016 and has held it in 24 quarters since.
  • Susquehanna International Group's BeOne Medicines Ltd position peaked at $6.07M in Q1 2020.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.